spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  dry eye syndrome 

 HSMN NewsFeed - 2 Mar 2022
RegeneRx Provides Regulatory Update Regarding RGN-259
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 21 Mar 2019
RegeneRx Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 Jan 2018
I-PEN(R), I-DROP(R) and I-PLUG(R) now available in Spain and Portugal through Partnership with IMEX
Devices Ophthalmology Distribution
 HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 29 Jan 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Jan 2016
BioLight Reports Positive Second Clinical Study Results for its TeaRx(TM) Multi-Assay Test for Dry Eye Syndrome
Diagnostics Ophthalmology
 HSMN NewsFeed - 20 Jan 2015
NovaBay Expands Sales Force for Avenova
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 31 Dec 2013
OphthaliX to Conduct a Retrospective Analysis of the Phase III Dry Eye Syndrome Study Data Based on the A3 Adenosine Receptor Biomarker
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Biopharmaceuticals Neurology Regenerative Medicine
 HSMN NewsFeed - 21 Dec 2011
Denali Concrete Management Inc. Announces the Commencement of Patient Enrollment for the Phase 3 Dry Eye Syndrome Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 18 Jul 2011
SARcode Bioscience Completes $44 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jan 2011
EyeGate Pharma Secures Additional $5.9M Series D Venture Funding
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 29 Apr 2010
EyeGate Pharma Establishes Research Collaboration With GlaxoSmithKline to Deliver Medicines Using the EyeGate(R) II Delivery System
Devices Biopharmaceuticals Drug Delivery Ophthalmology
 HSMN NewsFeed - 8 Jan 2010
EyeGate Pharma Secures $22M in Series D Venture Funding for Continued Development of EGP-437 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 21 Oct 2009
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
Diagnostics Ophthalmology Wound Care
 HSMN NewsFeed - 21 Oct 2009
MacuSight(R) Receives Fast Track Designation From FDA for Perceiva(TM) in Treatment of Diabetic Macular Edema
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 23 Jul 2009
Allergan Receives FDA Approval for ACUVAIL Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 5 May 2009
Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 9 Apr 2008
Novagali Pharma Announces the Launch of Cationorm(R)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Jan 2008
Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection
Biopharmaceuticals Ophthalmology Drug Delivery FDA
 HSMN NewsFeed - 18 Jan 2008
Novagali Pharma Announces FDA Clearance of IND for US Clinical Trial of Nova63035 in Patients With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 6 Nov 2007
Can-Fite: CF101 May Be Effective for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 2 Nov 2007
RegeneRx Receives First Ophthalmic Wound-Healing Patent in China
Biopharmaceuticals Wound Care Ophthalmology
 HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 31 Jul 2007
EMEA Committee for Orphan Medicinal Products Recommends Orphan Medicinal Product Designation for Lux Biosciences' LX211 for the Treatment of Uveitis
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 11 Jul 2007
Dr. William E. Cochran Joins arGentis Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2007
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Jun 2007
Novagali Pharma Strengthens its Executive Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2007
Novagali Pharma Receives US FDA Orphan Drug Designation for Vekacia(R) for the Treatment of Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Apr 2007
Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 4 Apr 2007
Novagali Pharma Announces Positive Vekacia(R) Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 15 Jan 2007
Lux Biosciences Receives Orphan Drug Designation from the FDA for Two Ophthalmic Products
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 28 Nov 2006
Lux Biosciences Receives FDA Clearance for LX211 IND
Biopharmaceuticals Ophthalmology FDA
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
dry eye syndrome
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.